渐进性肌性 - - 一个务实的审查
1Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
Neurology India
|March 12, 2026
概括
渐进性肌性 (PME) 是一种罕见的遗传性神经疾病. 本综述详细介绍了 PME 的情况.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 神经退行性疾病 神经退行性疾病
背景情况:
- 渐进性肌性 (PME) 包括罕见的遗传性神经退行性疾病.
- 关键特征包括肌肉,认知能力下降,和.
- 对于大约80%的 PME 病例,分子诊断是可用的.
研究的目的:
- 审查PME的临床表型,基因型和管理策略.
- 探索流行和新发现的 PME 形式,以改善临床评估.
- 建议应对这种具有挑战性的条件的管理方法.
主要方法:
- 在过去20年中对PME出版物的文献搜索,重点是过去十年.
- 搜索的数据库包括Medline,JSTOR和PubMed. 这些数据库的搜索数据库包括Medline,JSTOR和PubMed.
主要成果:
- 个人对 PME 症状的进展有很大差异.
- 主要的PME综合征包括拉波拉病,Unverricht-Lundborg病 (EPM1),带有纹红色纤维的肌细胞性 (MERRF) 和神经状体脂 (NCL).
- 临床和EEG发现有助于区分PME病因.
结论:
- 抗发作药物,如酸和perampanel用于管理.
- 尽管经过治疗,PME往往会随着潜在的治疗耐药性而逐渐发展.
- 了解遗传因素和临床特征对于有效管理PME至关重要.
相关概念视频
Epilepsy and Seizures: Overview
1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification
2.0K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.5K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K
Antiepileptic Drugs: Potassium Channel Activators
892
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
892
Antiepileptic Drugs: Glutamate Antagonists
1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K


